-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Theravance Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
- Theravance Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $2.65M, a 93.6% increase year-over-year.
- Theravance Biopharma, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $8.71M.
- Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $5.92M, a 65722% increase from 2022.
- Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $9K.
- Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2021 was -$151K, a 98.2% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)